Abbott's CardioMEMS Monitor Improves Quality Of Life In Study

Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations that you may have missed. Here is an update from the MONITOR HF study of Abbott's CardioMEMS implantable hemodynamic monitor.

Cardiovascular Catch-Up
• Source: Shutterstock

Results from the MONITOR HF trial, published in The Lancet, showedAbbott's CardioMEMS implantable hemodynamic monitor can improve heart failure patients’ quality of life.

The trial, sponsored by the Dutch Ministry of Health, Health Care Institute (Zorginstituut), and Abbott, randomized 348 heart-failure patients in...

More from Clinical Trials

More from R&D